Base5 Genomics develops an immunogenomic platform that provides patient-specific genomic references to enhance precision medicine. This technology addresses the limitations of standard genomic workflows by delivering contextualized biological ground truth for clinically significant regions of the human genome.
Funding
$4.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Standard genomic workflows often fail to capture the complexity of clinically significant regions of the human genome, hindering the effectiveness of precision medicine. These limitations can lead to inaccurate diagnoses and suboptimal treatment decisions for patients.
Solution
Base5 Genomics offers an immunogenomic platform that generates patient-specific genomic references, providing contextualized biological ground truth. This technology enhances precision medicine by addressing the limitations of standard genomic workflows. By capturing challenging and clinically important regions of the human genome, Base5 delivers a more accurate and comprehensive understanding of a patient's unique genomic profile. This enables clinicians to make more informed decisions, leading to improved patient outcomes.
Target Audience
The primary target audience includes researchers and clinicians in the precision medicine field who require more accurate and comprehensive genomic information for improved patient care.
Features
- Patient-specific genomic references for enhanced precision.
- Capture of clinically important and challenging genomic regions.
- Contextualized biological ground truth.